1. Home
  2. ASPS vs PLRX Comparison

ASPS vs PLRX Comparison

Compare ASPS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altisource Portfolio Solutions S.A.

ASPS

Altisource Portfolio Solutions S.A.

N/A

Current Price

$6.48

Market Cap

81.5M

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.16

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPS
PLRX
Founded
1999
2015
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.5M
70.6M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
ASPS
PLRX
Price
$6.48
$1.16
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$8.00
$2.67
AVG Volume (30 Days)
14.6K
620.5K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
112.00
29.97
EPS
N/A
N/A
Revenue
$942,213,000.00
N/A
Revenue This Year
$9.17
N/A
Revenue Next Year
$24.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$1.08
52 Week High
$15.96
$1.95

Technical Indicators

Market Signals
Indicator
ASPS
PLRX
Relative Strength Index (RSI) 36.10 51.90
Support Level $6.02 $1.12
Resistance Level $7.35 $1.37
Average True Range (ATR) 0.41 0.05
MACD -0.11 0.00
Stochastic Oscillator 2.25 78.70

Price Performance

Historical Comparison
ASPS
PLRX

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: